# Comprehensive HHT Outcomes Registry of the United States (CHORUS)

> **NCT06259292** · — · RECRUITING · sponsor: **Cure HHT** · enrollment: 10000 (estimated)

## Conditions studied

- Hereditary Hemorrhagic Telangiectasia
- Arteriovenous Malformations
- Telangiectasia
- Epistaxis
- GastroIntestinal Bleeding
- Cerebral Arteriovenous Malformations
- Vascular Malformation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06259292
- **Lead sponsor:** Cure HHT
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-13
- **Primary completion:** 2033-11
- **Final completion:** 2033-11
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2025-06-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06259292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06259292, "Comprehensive HHT Outcomes Registry of the United States (CHORUS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06259292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*